




Comprehensive DMD Model Portfolio
Our DMD models cover multiple mutation types — full knockout, point mutation, and exon deletion — reflecting the genetic heterogeneity of human DMD and enabling exon-skipping and gene therapy evaluation.
01

Multi-Endpoint Phenotypic Assessment
From motor function (rotarod, grip strength) to serum CK levels and histopathology, our models support thorough characterization of disease progression and therapeutic response.
02

Regulatory-Ready Study Design
From model selection to experimental endpoints, our team works closely with sponsors to tailor study protocols that align with specific research goals and regulatory requirements for DMD disease therapies.
03
B6-DMD Del52 Mice Exhibit Elevated CK Levels, Progressively Declining Motor Function, and Muscle Atrophy
Panel A and B: Mice exhibited motor dysfunction from 6 weeks of age.
All data represented as mean ± SEM. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, two-way ANOVA.
Panel C and D: B6-DMD Del52 mice exhibited elevated serum CK levels and (D) muscle atrophy (H&E stain) at 6 weeks of age. Blue arrow, muscle fiber atrophy; green arrow, muscle fiber necrosis; purple arrow, nuclear translocation; brown arrow, neutrophils; white arrow, macrophages. Scale bar: 50 μm.
Discover related models and services to accelerate your research


This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
Let us know which event you're attending and we'd be happy to connect with you.
